CATEGORIES

“Crovalimab could potentially become the first global drug originating from Singapore”
BioSpectrum Asia

“Crovalimab could potentially become the first global drug originating from Singapore”

There has been explosive growth in the mid- size molecules and therapeutic antibody market as many cancers, autoimmune diseases, metabolic diseases, and infectious diseases have been successfully treated.

time-read
4 mins  |
January 2023
New Zealand explores
BioSpectrum Asia

New Zealand explores

ways to improve clinical trials

time-read
1 min  |
January 2023
Singapore injects
BioSpectrum Asia

Singapore injects

1M into Global Fund for fighting AIDS, malaria and TB

time-read
1 min  |
January 2023
Japan approves manufacturing and marketing of Adtralza for atopic dermatitis
BioSpectrum Asia

Japan approves manufacturing and marketing of Adtralza for atopic dermatitis

Denmark-based LEO Pharma A/S, a global leader in medical dermatology, has announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has granted approval for the manufacturing and marketing of Adtralza (tralokinumab) subcutaneous injection

time-read
1 min  |
January 2023
Korea, Singapore strengthen bilateral cooperation over digital health medical devices
BioSpectrum Asia

Korea, Singapore strengthen bilateral cooperation over digital health medical devices

South Korean Ministry of Food and Drug Safety (MFDS) recently held a bilateral meeting with the Health Sciences Authority (HSA) of Singapore at Seoul to support the advancement of domestic medical devices into the global market and strengthen bilateral cooperation in the field of digital health medical devices

time-read
1 min  |
January 2023
India Discovers 3 Antiviral Molecules For Treating COVID-19
BioSpectrum Asia

India Discovers 3 Antiviral Molecules For Treating COVID-19

A team of researchers at Indian Institute of Technology (IIT) Roorkee has identified antiviral molecules that can be used effectively to treat COVID-19 infections.

time-read
1 min  |
December 2022
PerkinElmer launches industry-first readyto-use viral vector assays
BioSpectrum Asia

PerkinElmer launches industry-first readyto-use viral vector assays

PerkinElmer, Inc. has launched ready-to-use Adenoassociated Virus Vectors (AAV) Detection Kits to support researchers working on gene therapies for a variety of serious diseases.

time-read
1 min  |
December 2022
Agilent, Monash University collaborate to build Malaysia Integrated Biology Centre
BioSpectrum Asia

Agilent, Monash University collaborate to build Malaysia Integrated Biology Centre

Agilent Technologies has entered a new strategic partnership with Monash University Malaysia (Monash) to build a Malaysia integrated biology centre

time-read
1 min  |
December 2022
Nikon enters into Indian healthcare sector through microscopy biz
BioSpectrum Asia

Nikon enters into Indian healthcare sector through microscopy biz

Nikon India has announced its foray into India’s healthcare sector through System Product Microscopy business.

time-read
1 min  |
December 2022
Sartorius enters research partnership with The BASE Facility at University of Queensland
BioSpectrum Asia

Sartorius enters research partnership with The BASE Facility at University of Queensland

Germany-based Sartorius has entered a research partnership with The BASE Facility at The University of Queensland (UQ), Australia to improve the manufacturing process of nucleic acid products led by the external collaboration group, Separation Separation Technology Marketing team.

time-read
1 min  |
December 2022
Singapore links air polluting particles with cardiac arrests
BioSpectrum Asia

Singapore links air polluting particles with cardiac arrests

Small particles in air pollution in Singapore might have caused sudden cardiac arrests in some people who were not in hospital but simply going about their normal lives, according to scientists at Duke-NUS Medical School working with the National Environment Agency (NEA) as part of the PanAsian Resuscitation Outcomes Study (PAROS).

time-read
1 min  |
December 2022
New Zealand explores genomic sequencing to improve newborns' well-being
BioSpectrum Asia

New Zealand explores genomic sequencing to improve newborns' well-being

Researchers from the University of Auckland’s Liggins Institute in New Zealand are about to harness the technology of rapid genome sequencing in the hope of improving the well-being of critically ill newborn babies.

time-read
1 min  |
December 2022
Hong Kong uses novel computation methods to develop COVID-19 hotspot map
BioSpectrum Asia

Hong Kong uses novel computation methods to develop COVID-19 hotspot map

A research team led by Hong Kong Baptist University (HKBU) has launched the Hong Kong COVID-19 Hotspot Map which allows the intuitive visualisation of real-time and dynamic geographic distribution of COVID-19 cases in Hong Kong.

time-read
1 min  |
December 2022
Korea designs novel skinattachable auditory sensor
BioSpectrum Asia

Korea designs novel skinattachable auditory sensor

A research team at the Department of Chemical Engineering, Pohang University of Science and Technology (POSTECH), South Korea has developed a skin-attachable microphone sensor that clearly detects voices even in harsh noisy environments.

time-read
1 min  |
December 2022
Kyowa Kirin announces change in leadership position
BioSpectrum Asia

Kyowa Kirin announces change in leadership position

Kyowa Kirin, a Japan-based Global Specialty Pharmaceutical company, has announced the appointment of Abdul Mullick, President, Kyowa Kirin International (KKI), to a new role in the global organisation, as Vice Chief International Business Officer, reporting to the Global President.

time-read
1 min  |
December 2022
Healthify Me picks Stanford's Dr Shebani Sethi as Chief Medical Officer
BioSpectrum Asia

Healthify Me picks Stanford's Dr Shebani Sethi as Chief Medical Officer

In a first for a healthtech startup in India, Bengaluru-based HealthifyMe has announced the appointment of Dr Shebani Sethi as its consulting Chief Medical Officer (CMO).

time-read
1 min  |
December 2022
CARsgen names Dr Sylvie Peltier as SVP of global regulatory affairs
BioSpectrum Asia

CARsgen names Dr Sylvie Peltier as SVP of global regulatory affairs

China-based startup CARsgen Therapeutics Holdings has announced that Dr Sylvie Peltier has been appointed as Senior Vice President (SVP) of Global Regulatory Affairs of the company.

time-read
1 min  |
December 2022
Smith+Nephew opens academy in Singapore
BioSpectrum Asia

Smith+Nephew opens academy in Singapore

Smith+Nephew, the global medical technology company, has announced the opening of Smith+Nephew (S+N) Academy Singapore, a major medical education and digital innovation centre covering the Asia-Pacific region.

time-read
1 min  |
December 2022
India sets up Academic Chair in Ayurvedic Science at Western Sydney University
BioSpectrum Asia

India sets up Academic Chair in Ayurvedic Science at Western Sydney University

The Ministry of Ayush, Government of India, has formally announced the setting up of an Ayurveda Academic Chair based at Western Sydney University’s NICM Health Research Institute, with tenure for a period of three years.

time-read
1 min  |
December 2022
Mahidol University adopts virtual reality for medical education
BioSpectrum Asia

Mahidol University adopts virtual reality for medical education

Japan-based Jolly Good Inc., in collaboration with Juntendo University, will commence a demonstration project for the introduction of medical education with virtual reality (VR) for the purpose of developing medical human resources through the use of VR at Royal Mahidol University and throughout Thailand.

time-read
1 min  |
December 2022
Rounding up Digital Health Advancements across APAC in 2022
BioSpectrum Asia

Rounding up Digital Health Advancements across APAC in 2022

Over the past two years, Digital Health has been propelled into a realm of new care to create better efficiency, patient experience, while improving patient outcomes.

time-read
4 mins  |
December 2022
Healthcare Consumerisation Driving the Demand for Home Diagnostic Innovations in Asia
BioSpectrum Asia

Healthcare Consumerisation Driving the Demand for Home Diagnostic Innovations in Asia

The healthcare industry is witnessing a major shift in patient behaviour-- patients are more independent and aware of their health and well-being.

time-read
5 mins  |
December 2022
"There are many diseases for which mRNA approaches will be life-saving, including cancers"
BioSpectrum Asia

"There are many diseases for which mRNA approaches will be life-saving, including cancers"

What are your views on the current application and future perspectives of CRISPR/Cas9 mediated gene editing technology in developing new disease treatments? CRISPR/Caso9 gene editing is very powerful, but, not yet, as highly accurate as one would like.

time-read
2 mins  |
December 2022
A Powerful Performance
BioSpectrum Asia

A Powerful Performance

Allplex SARS-CoV-2 Assay by Seegene Inc

time-read
1 min  |
December 2022
Powering it with RNA
BioSpectrum Asia

Powering it with RNA

Aspin off from Agency of Science, Technology and Research A*STAR), Singapore-based startup MiRXES has commercialised its technology and eveloped accurate multi-cancer early detection solutions and made them readily available and accessible to people who need them.

time-read
1 min  |
December 2022
Revolutionising Healthcare with New-age Tech
BioSpectrum Asia

Revolutionising Healthcare with New-age Tech

Brain Navi Biotechnology, founded in 2015, is located in Hsinchu Biomedical Science Park in Taiwan.

time-read
1 min  |
December 2022
Accelerating Drug Discovery
BioSpectrum Asia

Accelerating Drug Discovery

Hummingbird Bioscience, founded in 2015, is an innovative clinical-stage biotech startup focused on developing precision therapies against hard-to drug targets to improve treatment outcomes.

time-read
1 min  |
December 2022
Lunit Lunit Inc Conquering Cancer With Al
BioSpectrum Asia

Lunit Lunit Inc Conquering Cancer With Al

South Korea-based Lunit Inc is a public company that develops medical artificial intelligence (AI) software that helps conquer cancer.

time-read
1 min  |
December 2022
Far-reaching Impact
BioSpectrum Asia

Far-reaching Impact

Dr Parul Ganju, a PhD in skin biology, from National Institute of Immunology (NII), New Delhi cofounded Ahammune Biosciences in 2016 in Pune, with Dr Krishnamurthy Natarajan, Professor, Jawaharlal Nehru University (JNU), New Delhi.

time-read
1 min  |
December 2022
Applying Deep Learning Experience to Drug Discovery
BioSpectrum Asia

Applying Deep Learning Experience to Drug Discovery

A leader in next-generation artificial intelligence (AI) technologies for drug discovery and biomarker development, Alex Zhavoronkov, PhD, is the founder and Chief Executive Officer of Hong Kong headquartered startup Insilico Medicine.

time-read
1 min  |
December 2022